Group 1 - Standex International Corporation has acquired Custom Biogenic Systems for approximately $6.2 million in cash, financed from its existing cash balance [1] - The acquisition is expected to be accretive to Standex's earnings in its first year of ownership and will be reported under the Scientific business segment [1][2] - Custom Biogenic Systems is a leader in the design and manufacturing of laboratory products, specializing in advanced cryogenic equipment, with estimated revenues of approximately $15 million for calendar year 2024 [3][4] Group 2 - The acquisition expands Standex's reach in the scientific refrigeration business, particularly in the liquid nitrogen and controlled rate freezer markets, enhancing North American manufacturing capabilities [2][4] - The addition of CBS is seen as complementary to Standex's existing product offerings, with a focus on customer intimacy and long-term combined potential [2][4] - Custom Biogenic Systems has over thirty years of industry experience, positioning it as a brand leader in cryogenic storage [4]
STANDEX ACQUIRES CUSTOM BIOGENIC SYSTEMS